A cross-sectional survey of patients and caregivers receiving Blincyto in routine clinical practice in Europe to evaluate the effectiveness of additional risk minimisation measures

22/02/2017
22/02/2024
EU PAS number:
EUPAS17829
Study
Finalised
Documents
Study protocol
Initial protocol
English (2.84 MB - PDF) View document
Updated protocol
English (1.98 MB - PDF) View document
Study results
Study results
English (153.97 KB - PDF) View document
Study report
Other information